- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- KBSW: 1.00
- ADC: 1.00
- KBEP: 1.00
- Cost: Free
- Release: Nov 1, 2015
- Expires: Oct 31, 2017
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
Assistant Professor of Psychiatry
Associate Program Director, Child & Adolescent Psychiatry
College of Medicine
University of Kentucky
Dr. Laurie L. Humphries Endowed Chair in Child Psychiatry
Division Director of Child and Adolescent Psychiatry
Professor of Psychiatry
Department of Psychiatry
College of Medicine
University of Kentucky
Needs StatementThe goal of the Adolescent Health and Recovery Treatment and Training (AHARTT) learning modules is to educate providers in Kentucky and beyond about evidence-based substance abuse treatments for adolescents and their families.
There is a lack of knowledge regarding available tools for screening adolescent substance use disorders. Therefore, practitioners are not routinely screening patients with a validated instrument for alcohol, tobacco, and illicit drug use.
Target AudiencePhysicians, Pharmacists, Health Administrators, Nurses, Nurse Practitioners, Social Workers, Drug and Alcohol Counselors, and practitioners of addiction medicine.
ObjectivesUpon completion of this activity participants will be able to:
1. Describe the importance of the use of a validated screening tool.
2. Cite two validated screening instruments.
3. Review tools for the implementation of screening, brief interview, & treatment into their clinical practice.
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
This training has been approved by the KBML as meeting the statutory requirements of HB1.
- Patient care
- Medical knowledge
- Practice-based learning and improvement
- Interpersonal and communication skills
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This knowledge-based activity has been assigned UAN 0022-0000-15-138-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.KBSW
This activity has been approved by the Kentucky Board of Social Work for 1.00 hours. ADC
This educational activity was designated for 1.00 hour. This course is approved by the Kentucky Board of Certification of Alcohol and Drug Counselors and is co-sponsored by UKHealthCare CECentral (). KBEP
The University of Kentucky is authorized by the Kentucky Board of Examiners in Psychology to provide continuing education for psychologists.
Faculty DisclosureNo speakers, authors, planners or content reviewers have any relevant financial relationships to disclose.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.